| # | Drug | Count |
|---|---|---|
| 0 | ERGOCALCIFEROL | 31 |
| 1 | ERENUMAB-AOOE | 24 |
| 2 | LAMOTRIGINE | 23 |
| 3 | LAMOTIRIGINE | 21 |
| 4 | LAMOTRIGINE CHEWABLE DISPERSIBLE | 21 |
| 5 | LAMOTRIGINE EXTENDED-RELEASE | 21 |
| 6 | MAGNESIUM | 19 |
| 7 | ONABOTULINUMTOXINA | 18 |
| 8 | ACETAMINOPHEN | 16 |
| 9 | TOPIRAMATE | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ESTRADIOL VALERATE | 7 | 0.0090 |
| 1 | FLURANDRENOLIDE | 1 | 0.0030 |
| 2 | SEGESTERONE ACETATE AND ETHINYL ESTRADIOL | 1 | 0.0026 |
| 3 | CALCIUM ANTACID | 1 | 0.0023 |
| 4 | OCRELIZUMAB AND HYALURONIDASE | 1 | 0.0020 |
| 5 | ZONISAMIDE | 14 | 0.0013 |
| 6 | DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE | 1 | 0.0012 |
| 7 | CEFTAROLINE FOSAMIL | 1 | 0.0012 |
| 8 | LUSPATERCEPT | 3 | 0.0011 |
| 9 | ERGOCALCIFEROL | 31 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 31 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 29 |
| 2 | Mood Stabilizer [EPC] | 25 |
| 3 | Anti-epileptic Agent [EPC] | 23 |
| 4 | Acetylcholine Release Inhibitor [EPC] | 19 |
| 5 | Neuromuscular Blocker [EPC] | 19 |
| 6 | Benzodiazepine [EPC] | 17 |
| 7 | Corticosteroid [EPC] | 16 |
| 8 | Atypical Antipsychotic [EPC] | 15 |
| 9 | Estrogen [EPC] | 15 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 9 | 0.0013 |
| 1 | Erythroid Maturation Agent [EPC] | 3 | 0.0011 |
| 2 | Provitamin D2 Compound [EPC] | 31 | 0.0010 |
| 3 | Calcitonin Gene-related Peptide Antagonist [EPC] | 8 | 0.0008 |
| 4 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0006 |
| 5 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 6 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 7 | Progestin Antagonist [EPC] | 1 | 0.0002 |
| 8 | Thyroid Hormone Synthesis Inhibitor [EPC] | 2 | 0.0002 |
| 9 | Catechol-O-Methyltransferase Inhibitor [EPC] | 1 | 0.0002 |